BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26920719)

  • 1. Regulation of sesquiterpenoid metabolism in recombinant and elicited Valeriana officinalis hairy roots.
    Ricigliano V; Kumar S; Kinison S; Brooks C; Nybo SE; Chappell J; Howarth DG
    Phytochemistry; 2016 May; 125():43-53. PubMed ID: 26920719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional identification of valerena-1,10-diene synthase, a terpene synthase catalyzing a unique chemical cascade in the biosynthesis of biologically active sesquiterpenes in Valeriana officinalis.
    Yeo YS; Nybo SE; Chittiboyina AG; Weerasooriya AD; Wang YH; Góngora-Castillo E; Vaillancourt B; Buell CR; DellaPenna D; Celiz MD; Jones AD; Wurtele ES; Ransom N; Dudareva N; Shaaban KA; Tibrewal N; Chandra S; Smillie T; Khan IA; Coates RM; Watt DS; Chappell J
    J Biol Chem; 2013 Feb; 288(5):3163-73. PubMed ID: 23243312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic engineering of Escherichia coli for production of valerenadiene.
    Nybo SE; Saunders J; McCormick SP
    J Biotechnol; 2017 Nov; 262():60-66. PubMed ID: 28988031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraction of valerenic acids from valerian (Valeriana officinalis L.) rhizomes.
    Boyadzhiev L; Kancheva D; Gourdon C; Metcheva D
    Pharmazie; 2004 Sep; 59(9):727-8. PubMed ID: 15497760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on chemical constituents of Valeriana officinalis].
    Jiang X; Zhang JC; Liu YW; Fang Y
    Zhong Yao Cai; 2007 Nov; 30(11):1391-3. PubMed ID: 18323205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-3 beta,4 beta-epoxyvalerenic acid from Valeriana officinalis.
    Dharmaratne HR; Nanayakkara NP; Khan IA
    Planta Med; 2002 Jul; 68(7):661-2. PubMed ID: 12143008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volvalerine A, an unprecedented N-containing sesquiterpenoid dimer derivative from Valeriana officinalis var. latifolia.
    Wang PC; Ran XH; Luo HR; Ma QY; Zhou J; Hu JM; Zhao YX
    Fitoterapia; 2016 Mar; 109():174-8. PubMed ID: 26779941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant effect and study of bioactive components of Valeriana sisymbriifolia and Nardostachys jatamansii in comparison to Valeriana officinalis.
    Dugaheh MA; Meisami F; Torabian Z; Sharififar F
    Pak J Pharm Sci; 2013 Jan; 26(1):53-8. PubMed ID: 23261727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiolytic properties of Valeriana officinalis in the zebrafish: a possible role for metabotropic glutamate receptors.
    Del Valle-Mojica LM; Ortíz JG
    Planta Med; 2012 Nov; 78(16):1719-24. PubMed ID: 22923195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic synthesis of valerena-4,7(11)-diene by a unique sesquiterpene synthase from the valerian plant (Valeriana officinalis).
    Pyle BW; Tran HT; Pickel B; Haslam TM; Gao Z; MacNevin G; Vederas JC; Kim SU; Ro DK
    FEBS J; 2012 Sep; 279(17):3136-46. PubMed ID: 22776156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats.
    Murphy K; Kubin ZJ; Shepherd JN; Ettinger RH
    Phytomedicine; 2010 Jul; 17(8-9):674-8. PubMed ID: 20042323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volvalerelactones A and B, two new sesquiterpenoid lactones with an unprecedented skeleton from Valeriana officinalis var. latifolia.
    Wang PC; Ran XH; Luo HR; Hu JM; Chen R; Ma QY; Dai HF; Liu YQ; Xie MJ; Zhou J; Zhao YX
    Org Lett; 2011 Jun; 13(12):3036-9. PubMed ID: 21591723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iridoids and sesquiterpenoids from the roots of Valeriana officinalis.
    Wang PC; Hu JM; Ran XH; Chen ZQ; Jiang HZ; Liu YQ; Zhou J; Zhao YX
    J Nat Prod; 2009 Sep; 72(9):1682-5. PubMed ID: 19691292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of Salvia castanea Diels f. tomentosa Stib. hairy root cultures and the promotion of tanshinone accumulation and gene expression with Ag⁺, methyl jasmonate, and yeast extract elicitation.
    Li B; Wang B; Li H; Peng L; Ru M; Liang Z; Yan X; Zhu Y
    Protoplasma; 2016 Jan; 253(1):87-100. PubMed ID: 25783026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iridoids and sesquiterpenoids from the roots of Valeriana jatamansi Jones.
    Dong FW; Liu Yang ; Wu ZK; Wei-Gao ; Zi CT; Dan Yang ; Luo HR; Jun Zhou ; Hu JM
    Fitoterapia; 2015 Apr; 102():27-34. PubMed ID: 25665939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability control of valerian ground material and extracts: a new HPLC-method for the routine quantification of valerenic acids and lignans.
    Goppel M; Franz G
    Pharmazie; 2004 Jun; 59(6):446-52. PubMed ID: 15248459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo synthesis of the sedative valerenic acid in Saccharomyces cerevisiae.
    Wong J; d'Espaux L; Dev I; van der Horst C; Keasling J
    Metab Eng; 2018 May; 47():94-101. PubMed ID: 29545148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valeriana officinalis extract and its main component, valerenic acid, ameliorate D-galactose-induced reductions in memory, cell proliferation, and neuroblast differentiation by reducing corticosterone levels and lipid peroxidation.
    Nam SM; Choi JH; Yoo DY; Kim W; Jung HY; Kim JW; Kang SY; Park J; Kim DW; Kim WJ; Yoon YS; Hwang IK
    Exp Gerontol; 2013 Nov; 48(11):1369-77. PubMed ID: 24055511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4.
    Lefebvre T; Foster BC; Drouin CE; Krantis A; Livesey JF; Jordan SA
    J Pharm Pharm Sci; 2004 Aug; 7(2):265-73. PubMed ID: 15367385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sesquiterpenoids and iridoid glycosides from Valeriana fauriei.
    Nishiya K; Kimura T; Takeya K; Itokawa H
    Phytochemistry; 1992 Oct; 31(10):3511-4. PubMed ID: 1368860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.